IL-35 stimulation impaired the proliferative and killing abilities of γδ T cells against HCC cells, increased the expression of exhaustion markers (PDCD1 and LAG3) and hampered cytokine secretion. This evidence concerns the gene PDCD1 and hepatocellular carcinoma.